CARMEN MAYO: Open Payments
NPI 1164863056 · KERNERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,425 in 203 payments from 31 companies in 2025. Trend: 2023 $2,964 · 2024 $3,133 · 2025 $3,425
Food & beverage: $3,425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $896 |
| PFIZER INC. | 32 | $431 |
| Novo Nordisk Inc | 20 | $292 |
| AstraZeneca Pharmaceuticals LP | 11 | $217 |
| Corcept Therapeutics | 5 | $163 |
| Amgen Inc. | 9 | $153 |
| Vanda Pharmaceuticals Inc. | 9 | $147 |
| Otsuka America Pharmaceutical, Inc. | 6 | $131 |
| GlaxoSmithKline, LLC. | 6 | $112 |
| Lilly USA, LLC | 7 | $108 |
Products named: QULIPTA, NURTEC ODT, VRAYLAR, UBRELVY, Korlym, REXULTI, Wegovy, Repatha.
Industry payments across NC — which companies pay providers there.
